BRIEF-Regeneron Pharmaceuticals says declined to submit new bid on 23andMe exceeding original $256 mln

Reuters
17 Jun
BRIEF-Regeneron Pharmaceuticals says declined to submit new bid on 23andMe exceeding original $256 mln

June 16 (Reuters) - 23andMe Holding Co MEHCQ.PK:

  • REGENERON PHARMACEUTICALS ON 23ANDME BID SAYS DECLINED TO SUBMIT A NEW BID EXCEEDING ORIGINAL WINNING BID OF $256 MILLION

Source text: [ID:]

Further company coverage: MEHCQ.PK

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10